KATHRYN DEACON: Open Payments
NPI 1598289746 · MAYFLOWER, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 53 payments from 14 companies in 2025. Trend: 2023 $1,131 · 2024 $1,362 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $233 |
| PFIZER INC. | 10 | $169 |
| ABBVIE INC. | 9 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Lilly USA, LLC | 4 | $61 |
| Novo Nordisk Inc | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Amgen Inc. | 3 | $46 |
Products named: AIRSUPRA, NURTEC ODT, CAPLYTA, VRAYLAR, QULIPTA, SHINGRIX, MOUNJARO, FARXIGA.
Industry payments across AR — which companies pay providers there.
